Latest
Find the latest updates, upcoming scientific events, and curated resources to stay connected with ongoing research and collaboration opportunities.
Publications
Gut Microbiota in Immuno-Oncology: A Practical Guide for Medical Oncologists With a Focus on Antibiotics Stewardship
ASCO Educational Book
Pharmacomicrobiomics: The Role of the Gut Microbiome in Immunomodulation and Cancer Therapy
Pharmacomicrobiomics Review
White Paper: Can Antibiotics undermine Cancer Immunotherapy Outcomes?
Coming Later 2025
Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancer
Derosa 2018
Antibiotics are associated with worse outcomes in lung cancer patients treated with chemotherapy and immunotherapy
Elkrief 2024
Events
ESMO Congress 2025
17-21 October 2025
Berlin, Germany
The ESMO Congress is a highly influential global oncology platform for clinicians, researchers, patient advocates, journalists and healthcare industry representatives from all over the world.
ASCO Annual Meeting 2025
30 May-03 June 2025
Chicago, USA
The 2025 ASCO Annual Meeting will focus on driving cancer research into actionable change, in line with Dr. Robin Zon’s theme Driving Knowledge to Action: Building a Better Future.
PIO Annual Meeting 2025
16-17 June 2025
Paris, France
The 2025 Paris Immuno-Oncology Conference (PIO) will focus on Tumor Immunology & Immunotherapy and the Microbiota-Immune Interface. Together, we will explore the links between cancer, immunity, and the microbiota, and discuss innovative therapeutic strategies to harness the body’s ecosystem against cancer.
Resources
TOPOSCORE
A proxy for gut dysbiosis calculated using species-interacting groups (SIGs) that correlate with overall survival.